483
Gland Pharma LimitedFDA 483 - Gland Pharma Limited - November 01, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Gland Pharma Limited, a sterile drug manufacturer in Visakhapatnam, revealed two significant observations. The firm failed to adequately validate its aseptic and sterilization processes, raising concerns about microbiological contamination control. Additionally, investigations into unexplained discrepancies lacked thoroughness, conclusions, and follow-up actions.
Open in Dashboard
ID · cb276665-92aa-427d-b63e-73e0bdec767a